Effect of Cremophor-EL on Cisplatin-Induced Organ Toxicity in Normal Rat

L. Ramadan,O. El-Habit,H. Arafa,Mohamad M. Sayed-Ahmad
Abstract:Cisplatin in an inorganic platinum compound with a broad spectrum antineoplastic activity against different types of tumours. Pharmacological and cytogenetic evaluations of the possible protective effects of cremophor-EL (cremophor) against cisplatin-induced nephro-, hepatoand bone marrow toxicity in normal rats were carried out. A single dose of cisplatin (7.5 mg/kg i.v.) caused acute nephrotoxicity biochemically manifested as an increase in serum urea nitrogen (528%) and serum creatinine (1307%). Serum alanine and aspartate aminotransferase levels were also increased. In the liver tissue, glutathione level (GSH) decreased significantly 7 days after cisplatin treatment. Cisplatin caused a significant increase in the frequency of micronuclei (MN) of polychromatic erythrocytes (PCEs) and normochromatic erythrocytes (NCEs), as well as the ratio of PCEs/NCEs. Moreover, a significant delay in the mitotic activity was observed after cisplatin treatment. Administration of cremophor at a dose of 50 µl/ kg intravenously 5 minutes before cisplatin protected the kidney and liver as indicated by restoration of urea and creatinine concentrations, as well as aminotransferase activities. Pretreatment with cremophor resulted in a significant recovery in the frequency of cisplatin-induced increase in MV, in the ratio of PCEs/NCEs, as well as in the MI of bone marrow. Administration of cremophor before cisplatin did not interfere with the antitumour activity of cisplatin in EAC-bearing mice. These results suggest that cremophor administration may play a role to prevent cisplatin-induced damage to the kidney, liver and bone marrow without interfering with its antitumour activity.
What problem does this paper attempt to address?